Cardiff Oncology (NASDAQ:CRDF – Free Report) had its target price trimmed by HC Wainwright from $14.00 to $13.00 in a report issued on Tuesday morning, MarketBeat.com reports. The firm currently has a buy rating on the stock. Cardiff Oncology Price Performance Shares of NASDAQ:CRDF opened at $2.07 on Tuesday. The business’s fifty day moving average […]
Financialnewsmedia.com: Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year's End finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Gainers Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares surged 83.5% to $0.1648 in pre-market trading after falling over 25% on Monday. The company recently announced its plans to reduce the company's headcount by 78%.